Safety and Efficacy of β-Blockers in the Treatment of Stable Angina Pectoris
The DOI matches its Crossref record.
Abstract
In stable exercise-induced angina pectoris. β-blockers exert their beneficial effects mainly through a reduction in heart rate. blood pressure. and contractility. Additional beneficial effects are an improvement in myocardial oxygen supply through a redistribution of coronary flow, a lengthening of diastole, a facilitation of aerobic metabolism. and a rightward shift of the oxygen-hemoglobin dissociation curve. Cardioselective β-blockers can be expected to have fewer side effects than the nonselective drugs. Apart from a reduction in anginal attack rate and an improvement in exercise capacity, a reduction in silent ischemia may be desirable when treating patients with stable effort angina. β-blockers effectively reduce asymptomatic ischemia. Bisoprolol is a new β1-selective β-blocker with a clear 24-h duration of action regarding symptoms and improvement of exercise capacity in patients with stable exercise-induced angina pectoris. Bisoprolol 10 mg and atenolol 100 mg are equipotent in achieving these effects.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, β-blockers may increase exercise capacity in those with CAD, rather than lowering it, by reducing coronary ischemia during activity ( 53 ).”
From Exercise and Type 2 Diabetes (2010) · cites this paper as [53]
Citations
Cites
Still being checked.
Cited by
Colberg, S. R., Sigal, R. J., Fernhall, B., Regensteiner, J. G., Blissmer, B. J., Rubin, R. R., Chasan-Taber, L., Albright, A. L., & Braun, B. (2010) · Diabetes Care · doi:10.2337/dc10-9990 · Cited by 1,955
Physical Activity/Exercise and Type 2 Diabetes
Sigal, R. J., Kenny, G. P., Wasserman, D. H., Castaneda-Sceppa, C., & White, R. D. (2006) · Diabetes Care · doi:10.2337/dc06-9910 · Cited by 949
KANALEY, J. A., COLBERG, S. R., CORCORAN, M. H., MALIN, S. K., RODRIGUEZ, N. R., CRESPO, C. J., KIRWAN, J. P., & ZIERATH, J. R. (2022) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000002800 · Cited by 931
Systemic adverse effects of beta-adrenergic blockers: an evidence-based assessment
Lama, P. J. (2002) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(02)01699-9 · Cited by 116
Prescribing Exercise for Individuals with Type 2 Diabetes: Recommendations and Precautions
Colberg, S. R., & Sigal, R. J. (2011) · The Physician and Sportsmedicine · doi:10.3810/psm.2011.05.1909 · Cited by 28
Metadata
- Authors
- de Muinck, E. D., & Lie, K. I.
- Affiliations
- University Medical Center Groningen (NL)
- ORCID
- Lie, K. I.
- Venue
- Journal of Cardiovascular Pharmacology
- Published
- 1990
- Volume
- 16
- Pages
- S123-S128
- ISSN
- 0160-2446 (ISSN-L)
- OpenAlex
- W4242057232
- Cited by
- 10
- References
- 0
- Citations by year
- 2025: 5 · 2021: 1
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Cardiovascular Pharmacology (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart rate and cardiovascular health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Coronary Interventions and Diagnostics
- Keywords
- beta-blockers, stable angina, bisoprolol, atenolol, cardioselective beta-blockers, exercise-induced angina, silent myocardial ischemia, exercise capacity, myocardial oxygen supply, heart rate reduction, drug safety and efficacy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Safety and Efficacy of β-Blockers in the Treatment of Stable Angina Pectoris. https://app.cochat.ai/papers/10.1097/00005344-199006165-00022
- The paper
- de Muinck, E. D., & Lie, K. I. (1990). Safety and Efficacy of β-Blockers in the Treatment of Stable Angina Pectoris. Journal of Cardiovascular Pharmacology. https://doi.org/10.1097/00005344-199006165-00022
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.